News & Events

The Firm represented the initial purchasers in connection with a Rule 144A/Regulation S offering of US$1.5 billion of 1.031% Senior Notes due 2015 and $1.5 billion of 1.625% Senior Notes due 2017 by Japan's Takeda Pharmaceutical Company Limited.  Nomura Securities International, Inc., J.P. Morgan Securities LLC, Merrill Lynch, Pierce, Fenner & Smith Incorporated, Citigroup Global Markets Inc. and Morgan Stanley & Co. LLC were the Joint Lead Managers for the offering.

Takeda is Japan's largest pharmaceutical company.  Takeda will use the net proceeds from the offering to partially repay bank debt incurred in connection with its 2011 acquisition of Nycomed, a leading pharmaceutical company in the European markets and emerging markets.

The Simpson Thacher team for the offering included David Sneider, Alan Cannon, Tadashi Okamoto, Vincent Pace and Jasmine Kaufman (Capital Markets), Vanessa Cohen (Tax), and Jeanne Annarumma and Sarah Dale (Executive Compensation and Employee Benefits).